Adverse events: other · adults with chronic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: other · adults with chronic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe adverse events · adults with renal vasculitis for maintenance therapy
Azathioprine may leads to lower severe adverse events compared with methotrexate (low certainty).
1 finding from 1 review
Severe adverse events · people with acute ischemic stroke
Citicoline showed no clear difference in severe adverse events compared with placebo or standard treatment (low certainty).
1 finding from 1 review
Adverse events: death · idiopathic steroid‐resistant nephrotic syndrome in children
Calcineurin inhibitor showed no clear difference in adverse events: death compared with IV cyclophosphamide (low certainty).
1 finding from 1 review
Adverse events, total · people with probable or definite amyotrophic lateral sclerosis/motor neuron disease (treated with riluzole)
BM‐MSC showed no clear difference in adverse events, total compared with no treatment (low certainty).
1 finding from 1 review
Total adverse eventsg · drug‐resistant pulmonary tuberculosis
1 finding from 1 review
Sexual adverse events
Naftopidil probably leads to lower sexual adverse events compared with silodosin (alpha‐blocker) (moderate certainty).
1 finding from 1 review
Sexual adverse events
Naftopidil showed no clear difference in sexual adverse events compared with tamsulosin (alpha‐blocker) (low certainty).
1 finding from 1 review
Severe adverse events · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
1 finding from 1 review
Severe adverse events · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
1 finding from 1 review
Adverse events: death · people requiring admission to hospital
It is very uncertain whether hospital‐in‐the‐home changes adverse events: death compared with hospital admission (very low certainty).
1 finding from 1 review
Severe adverse events
4 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Show 1 more finding
Adverse events: nausea · people with delirium
Cholinesterase inhibitors (rivastigmine) showed no clear difference in adverse events nausea compared with placebo (low certainty).
1 finding from 1 review
Adverse events: renal · men with advanced prostate cancer
Bisphosphonates probably leads to higher adverse events: renal compared with placebo/no treatment (moderate certainty).
1 finding from 1 review
Sexual adverse events
Silodosin probably leads to higher sexual adverse events compared with tamsulosin (moderate certainty).
1 finding from 1 review
Sexual adverse events
Silodosin probably leads to higher sexual adverse events compared with naftopidil (moderate certainty).
1 finding from 1 review
Sexual adverse events
Silodosin probably leads to higher sexual adverse events compared with alfuzosin (moderate certainty).
1 finding from 1 review
Sexual adverse events
Silodosin probably leads to higher sexual adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Severe adverse events · children with tinea capitis
Complete cure and adverse events for terbinafine showed no clear difference in severe adverse events compared with griseofulvin (moderate certainty).
1 finding from 1 review